159 related articles for article (PubMed ID: 11922473)
1. Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation.
Lewis AL; Tolhurst LA; Stratford PW
Biomaterials; 2002 Apr; 23(7):1697-706. PubMed ID: 11922473
[TBL] [Abstract][Full Text] [Related]
2. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo.
Lewis AL; Willis SL; Small SA; Hunt SR; O'byrne V; Stratford PW
Biomed Mater Eng; 2004; 14(4):355-70. PubMed ID: 15472385
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries.
Whelan DM; van der Giessen WJ; Krabbendam SC; van Vliet EA; Verdouw PD; Serruys PW; van Beusekom HM
Heart; 2000 Mar; 83(3):338-45. PubMed ID: 10677417
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility.
Malik N; Gunn J; Shepherd L; Crossman DC; Cumberland DC; Holt CM
J Invasive Cardiol; 2001 Mar; 13(3):193-201. PubMed ID: 11231644
[TBL] [Abstract][Full Text] [Related]
5. Long-term stability of a coronary stent coating post-implantation.
Lewis AL; Furze JD; Small S; Robertson JD; Higgins BJ; Taylor S; Ricci DR
J Biomed Mater Res; 2002; 63(6):699-705. PubMed ID: 12418013
[TBL] [Abstract][Full Text] [Related]
6. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylcholine-coated metallic stents in rabbit iliac and porcine coronary arteries.
Kuiper KK; Robinson KA; Chronos NA; Cui J; Palmer SJ; Nordrehaug JE
Scand Cardiovasc J; 1998; 32(5):261-8. PubMed ID: 9834999
[TBL] [Abstract][Full Text] [Related]
8. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ
Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
[TBL] [Abstract][Full Text] [Related]
9. Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model.
Kipshidze NN; Iversen P; Kim HS; Yiazdi H; Dangas G; Seaborn R; New G; Tio F; Waksman R; Mehran R; Tsapenko M; Stone GW; Roubin GS; Iyer S; Leon MB; Moses JW
Catheter Cardiovasc Interv; 2004 Apr; 61(4):518-27. PubMed ID: 15065150
[TBL] [Abstract][Full Text] [Related]
10. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model.
Lincoff AM; Furst JG; Ellis SG; Tuch RJ; Topol EJ
J Am Coll Cardiol; 1997 Mar; 29(4):808-16. PubMed ID: 9091528
[TBL] [Abstract][Full Text] [Related]
11. Local methylprednisolone inhibition of foreign body response to coated intracoronary stents.
de Scheerder I; Wang K; Wilczek K; van Dorpe J; Verbeken E; Desmet W; Schacht E; Piessens J
Coron Artery Dis; 1996 Feb; 7(2):161-6. PubMed ID: 8813449
[TBL] [Abstract][Full Text] [Related]
12. New biocompatible polymer surface coating for stents results in a low neointimal response.
Bär FW; van der Veen FH; Benzina A; Habets J; Koole LH
J Biomed Mater Res; 2000 Oct; 52(1):193-8. PubMed ID: 10906692
[TBL] [Abstract][Full Text] [Related]
13. Optimization of local methylprednisolone delivery to inhibit inflammatory reaction and neointimal hyperplasia of coated coronary stents.
Huang Y; Wang L; Verweire I; Qiang B; Liu X; Verbeken E; Schacht E; De Scheerder I
J Invasive Cardiol; 2002 Sep; 14(9):505-13. PubMed ID: 12205348
[TBL] [Abstract][Full Text] [Related]
14. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I
Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906
[TBL] [Abstract][Full Text] [Related]
15. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
Richard R; Schwarz M; Chan K; Teigen N; Boden M
J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous polymeric stents in porcine coronary arteries. Initial experience with polyethylene terephthalate stents.
Murphy JG; Schwartz RS; Edwards WD; Camrud AR; Vlietstra RE; Holmes DR
Circulation; 1992 Nov; 86(5):1596-604. PubMed ID: 1423971
[TBL] [Abstract][Full Text] [Related]
17. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries.
van der Giessen WJ; Lincoff AM; Schwartz RS; van Beusekom HM; Serruys PW; Holmes DR; Ellis SG; Topol EJ
Circulation; 1996 Oct; 94(7):1690-7. PubMed ID: 8840862
[TBL] [Abstract][Full Text] [Related]
18. Biomimicry 1: PC.
Cumberland DC; Gunn J; Malik N; Holt CM
Semin Interv Cardiol; 1998; 3(3-4):149-50. PubMed ID: 10406685
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable phosphorylcholine copolymer for cardiovascular stent coating.
Liu J; Wang J; Xue YF; Chen TT; Huang DN; Wang YX; Ren KF; Wang YB; Fu GS; Ji J
J Mater Chem B; 2020 Jun; 8(24):5361-5368. PubMed ID: 32458930
[TBL] [Abstract][Full Text] [Related]
20. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.
Chan KH; Armstrong J; Withers S; Malik N; Cumberland DC; Gunn J; Holt CM
Biomaterials; 2007 Feb; 28(6):1218-24. PubMed ID: 17126396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
